UDG

CD&R Announces New Partners

Retrieved on: 
Tuesday, December 12, 2023
Accounting, Operating partner, Pfizer, Senior, Advent International, Software, Investment, Plex Systems, Honours degree, CD&R, Hakluyt & Company, Trinity College, Private sector, Culture, Senate, Partner, PTC, Public affairs, EQT Partners, University, Software as a service, Hakluyt, R, Growth, UDG, BMC Software, Counsel

NEW YORK, Dec. 12, 2023 /PRNewswire/ -- Clayton, Dubilier & Rice ("CD&R" or the "Firm") announced today the appointment of three new Partners – Sid Jhaver, Jon Selib and Bill Berutti.

Key Points: 
  • NEW YORK, Dec. 12, 2023 /PRNewswire/ -- Clayton, Dubilier & Rice ("CD&R" or the "Firm") announced today the appointment of three new Partners – Sid Jhaver, Jon Selib and Bill Berutti.
  • He has played a key role in the Firm's investments in UDG and the creation and development of Sharp and Inizio.
  • Mr. Jhaver has spent the majority of his career evaluating private investment opportunities in the healthcare sector.
  • Prior to joining CD&R, he worked for EQT Partners and Advent International.

Cavitation Technologies, Inc. and The University of Guadalajara Sign a Memorandum of Understanding

Retrieved on: 
Monday, July 24, 2023
Knowledge, University, Nano, Robert E. Kennedy (university dean), University of Guadalajara, Big data, UDG, Research, Science, The Company, Titanium carbide, Laboratory, Water, MOU, Dominican House of Studies, ESG, Ecosystem, Ecology, SA, House, Social Problems, Technology transfer, Director general, Management

The University of Guadalajara (UdG) signed a Memorandum of Understanding (MOU) with Cavitation Technologies, Inc (CTi), Meristemo Cultiva and Inaramex in connection with CTi’s Technology, a ceremony held at the José Clemente Orozco Room of the General Rectory building of this House of Study.

Key Points: 
  • The University of Guadalajara (UdG) signed a Memorandum of Understanding (MOU) with Cavitation Technologies, Inc (CTi), Meristemo Cultiva and Inaramex in connection with CTi’s Technology, a ceremony held at the José Clemente Orozco Room of the General Rectory building of this House of Study.
  • “The path is for the university to link up with the private initiative, for us to work together, for companies to trust in investing venture capital to develop technology, which is not something common in Mexico.
  • In Jalisco we have businessmen who bet more on income than on investment, and when there are businessmen who do take risks and who do invest, we have to live up to that,” Dr. Villanueva concluded.
  • The General Director of Inaramex (SA de CV), Aldo Medina, spoke of the importance of working together with the university in terms of technology implementation and producing it in Mexico.

CXV GLOBAL AND PANACEA TECHNOLOGIES COMBINE TO CREATE LEADING PROVIDER OF SOLUTIONS OPTIMIZING LIFE SCIENCES OPERATIONS

Retrieved on: 
Wednesday, October 12, 2022
Laboratory, Engineering, Water Street, System, Efficiency, Abbott Laboratories, Organization, UDG, Multimedia, Investment, Technology, Panacea, Automation, Solution, Goal, Industry, Water Street, Milwaukee, CEO, Health, United Kingdom, Ownership, View, UDG Healthcare, Fine chemical, Pharmaceutical industry, Management, Crest, Amici miei – Come tutto ebbe inizio

CORK, Ireland and PHILADELPHIA, Oct. 12, 2022 /PRNewswire/ -- CXV Global, a strategic alliance comprised of European and U.S.-based Crest Solutions, Xyntek Incorporated and VistaLink, announced today that it is combining the three businesses under common ownership with Philadelphia-headquartered Panacea Technologies. The transaction creates a leading global provider of automation and digitization solutions uniquely positioned to optimize life sciences organizations' worldwide operations.

Key Points: 
  • The transaction creates a leading global provider of automation and digitization solutions uniquely positioned to optimize life sciences organizations' worldwide operations.
  • Together, they offer life sciences companies a comprehensive portfolio of technologies and professional services that maximize the efficiency of their worldwide operations across their entire product life cycle.
  • CXV Global and Panacea Technologies offer a powerful platform of combined technologies and professional services that optimize life sciences' operations across product development, manufacturing, packaging and distribution.
  • CXV Global develops and delivers proprietary solutions to automate R&D, manufacturing, packaging and distribution operations for life sciences organizations.

CXV GLOBAL AND PANACEA TECHNOLOGIES COMBINE TO CREATE LEADING PROVIDER OF SOLUTIONS OPTIMIZING LIFE SCIENCES OPERATIONS

Retrieved on: 
Wednesday, October 12, 2022
Laboratory, Engineering, Water Street, System, Efficiency, Abbott Laboratories, Organization, UDG, Investment, Technology, Panacea, Automation, Solution, Goal, Industry, Water Street Historic District (Torrington, Connecticut), CEO, Health, United Kingdom, Ownership, UDG Healthcare, Fine chemical, Pharmaceutical industry, Management, Crest, Amici miei – Come tutto ebbe inizio

CORK, Ireland and PHILADELPHIA, Oct. 12, 2022 /PRNewswire/ -- CXV Global, a strategic alliance comprised of European and U.S.-based Crest Solutions, Xyntek Incorporated and VistaLink, announced today that it is combining the three businesses under common ownership with Philadelphia-headquartered Panacea Technologies. The transaction creates a leading global provider of automation and digitization solutions uniquely positioned to optimize life sciences organizations' worldwide operations.

Key Points: 
  • The transaction creates a leading global provider of automation and digitization solutions uniquely positioned to optimize life sciences organizations' worldwide operations.
  • Together, they offer life sciences companies a comprehensive portfolio of technologies and professional services that maximize the efficiency of their worldwide operations across their entire product life cycle.
  • CXV Global and Panacea Technologies offer a powerful platform of combined technologies and professional services that optimize life sciences' operations across product development, manufacturing, packaging and distribution.
  • CXV Global develops and delivers proprietary solutions to automate R&D, manufacturing, packaging and distribution operations for life sciences organizations.

New England Biolabs® Launches LyoPrime Luna™ RT-qPCR Master Mix, the First Lyophilized Product Since its Acquisition of Fluorogenics™

Retrieved on: 
Wednesday, February 9, 2022
LUNA, RT, Enzyme, Industry, RNA, DUTP diphosphatase, Multimedia, Temperature, Research, PCR, NEW, Perception, Catalog, Risk, Infection, Molecular biology, Associate Director of National Intelligence and Chief Information Officer, UDG, Synthetic biology, Gene expression, Real-time, NEB, View, Acquisition, Fine chemical, Amusement park, Cytidine monophosphate, New England Biolabs

IPSWICH, Mass., Feb. 9, 2022 /PRNewswire/ -- Today, New England Biolabs (NEB) announced the release of its first lyophilized product manufactured by Fluorogenics: the LyoPrime Luna Probe One-Step RT-qPCR Mix with UDG.

Key Points: 
  • IPSWICH, Mass., Feb. 9, 2022 /PRNewswire/ -- Today, New England Biolabs (NEB) announced the release of its first lyophilized product manufactured by Fluorogenics: the LyoPrime Luna Probe One-Step RT-qPCR Mix with UDG.
  • By lyophilizing our Luna WarmStart RT-based product, we've achieved a one-step RT-qPCR mix that provides the same high level of performance delivered by our liquid master mix.
  • The LyoPrime Luna RT-qPCR master mix represents NEB's first lyophilized product since the company's acquisition of Fluorogenics Limited in 2021.
  • NEB, NEW ENGLAND BIOLABS, WARMSTART and LUNA are registered trademarks of New England Biolabs, Inc.
    View original content to download multimedia: https://www.prnewswire.com/news-releases/new-england-biolabs-launches-ly...

New England Biolabs® Introduces Updated Versions of WarmStart® LAMP Reagents

Retrieved on: 
Tuesday, August 24, 2021
Industry, Polymerase chain reaction, PCR, NEB, Technology, Molecular biology, Fever Dream, DNA, RNA, NEW, Synthetic biology, Multimedia, LAMP, Temperature, DUTP diphosphatase, Enzyme, Solution, UDG, Gene, Malaria, COVID-19, View, Gene expression

With the introduction of a pH indicator, colorimetric LAMP has enabled the quick and easy visual detection of multiple diseases, including malaria, dengue and COVID-19.

Key Points: 
  • With the introduction of a pH indicator, colorimetric LAMP has enabled the quick and easy visual detection of multiple diseases, including malaria, dengue and COVID-19.
  • The WarmStart Fluorescent LAMP/RT-LAMP Kit pairs the master mix with LAMP fluorescent dye and supports real-time detection of LAMP reactions.
  • For more information about the WarmStart Multi-Purpose LAMP/RT-LAMP 2X Master Mix and WarmStart Fluorescent LAMP/RT-LAMP Kit, please visit www.neb.com/m1708 and www.neb.com/e1708 respectively.
  • NEB, NEW ENGLAND BIOLABS and WARMSTART are registered trademarks of New England Biolabs, Inc.
    View original content to download multimedia: https://www.prnewswire.com/news-releases/new-england-biolabs-introduces-...